KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Long-Term Deferred Tax (2017 - 2025)

Historic Long-Term Deferred Tax for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $2.8 billion.

  • Takeda Pharmaceutical's Long-Term Deferred Tax rose 1221.62% to $2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 1221.62%. This contributed to the annual value of $2.4 billion for FY2025, which is 1088.29% down from last year.
  • Takeda Pharmaceutical's Long-Term Deferred Tax amounted to $2.8 billion in Q4 2025, which was up 1221.62% from $2.6 billion recorded in Q3 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Long-Term Deferred Tax peaked at $3.3 billion during Q1 2021, and registered a low of $2.1 billion during Q4 2023.
  • In the last 5 years, Takeda Pharmaceutical's Long-Term Deferred Tax had a median value of $2.8 billion in 2023 and averaged $2.7 billion.
  • In the last 5 years, Takeda Pharmaceutical's Long-Term Deferred Tax skyrocketed by 2853.51% in 2021 and then tumbled by 1854.82% in 2023.
  • Takeda Pharmaceutical's Long-Term Deferred Tax (Quarter) stood at $3.1 billion in 2021, then decreased by 18.02% to $2.5 billion in 2022, then dropped by 15.78% to $2.1 billion in 2023, then rose by 15.52% to $2.5 billion in 2024, then increased by 12.22% to $2.8 billion in 2025.
  • Its Long-Term Deferred Tax stands at $2.8 billion for Q4 2025, versus $2.6 billion for Q3 2025 and $2.8 billion for Q2 2025.